MINAPHARM Pharmaceuticals (EGX:MIPH)
Egypt · Delayed Price · Currency is EGP 669.42
+15.74 (2.41%)
At close: Jun 4, 2026
MINAPHARM Pharmaceuticals Ratios and Metrics
Market cap in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 3, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 7,886 | 1,796 | 2,408 | 1,822 | 1,303 | 987 | |
Market Cap Growth | 301.32% | -25.41% | 32.19% | 39.82% | 32.02% | -5.49% |
Enterprise Value | 9,584 | 4,355 | 4,087 | 2,625 | 1,448 | 1,101 |
Last Close Price | 669.42 | 160.66 | 213.62 | 143.60 | 100.70 | 74.31 |
PE Ratio | 66.14 | 14.02 | - | 3.09 | 2.91 | 3.46 |
PS Ratio | 1.14 | 0.32 | 0.62 | 0.50 | 0.43 | 0.42 |
PB Ratio | 1.33 | 0.41 | 0.69 | 0.60 | 0.67 | 0.62 |
P/TBV Ratio | 1.50 | 0.48 | 0.80 | 0.70 | 0.81 | 0.79 |
P/FCF Ratio | - | - | - | - | - | 3.44 |
P/OCF Ratio | 20.94 | 8.11 | 23.53 | 3.24 | 6.29 | 2.26 |
EV/Sales Ratio | 1.38 | 0.77 | 1.05 | 0.73 | 0.48 | 0.47 |
EV/EBITDA Ratio | 5.73 | 3.72 | 7.63 | 2.42 | 1.73 | 1.77 |
EV/EBIT Ratio | 7.24 | 4.66 | 10.91 | 2.72 | 1.92 | 2.04 |
EV/FCF Ratio | -21.96 | - | - | - | - | 3.84 |
Debt / Equity Ratio | 0.91 | 1.24 | 1.07 | 0.80 | 0.64 | 0.60 |
Debt / EBITDA Ratio | 3.24 | 4.48 | 6.67 | 2.22 | 1.49 | 1.54 |
Debt / FCF Ratio | - | - | - | - | - | 3.34 |
Net Debt / Equity Ratio | 0.27 | 0.58 | 0.53 | 0.24 | 0.14 | -0.04 |
Net Debt / EBITDA Ratio | 0.98 | 2.19 | 3.47 | 0.68 | 0.32 | -0.10 |
Net Debt / FCF Ratio | -3.64 | -3.68 | -1.44 | -1.24 | -1.47 | -0.23 |
Asset Turnover | 0.55 | 0.55 | 0.50 | 0.66 | 0.79 | 0.74 |
Inventory Turnover | 3.31 | 3.26 | 2.79 | 2.82 | 2.90 | 2.73 |
Quick Ratio | 1.02 | 0.79 | 0.70 | 0.87 | 0.92 | 0.84 |
Current Ratio | 1.49 | 1.25 | 1.15 | 1.46 | 1.61 | 1.34 |
Return on Equity (ROE) | 2.89% | 4.06% | 0.68% | 25.32% | 26.86% | 21.14% |
Return on Assets (ROA) | 6.56% | 5.64% | 3.02% | 11.05% | 12.42% | 10.56% |
Return on Invested Capital (ROIC) | 8.36% | 8.71% | 5.54% | 23.09% | 28.67% | 25.84% |
Return on Capital Employed (ROCE) | 14.90% | 12.60% | 7.20% | 22.40% | 28.80% | 29.10% |
Earnings Yield | 1.42% | 8.74% | -1.33% | 33.63% | 35.79% | 30.47% |
FCF Yield | -5.53% | -38.82% | -53.66% | -32.84% | -13.86% | 29.06% |
Dividend Yield | 0.37% | 1.56% | 0.77% | 1.95% | 2.90% | 3.63% |
Payout Ratio | 36.96% | 25.57% | - | 9.43% | 10.68% | 29.33% |
Buyback Yield / Dilution | - | - | 3.57% | 6.67% | - | - |
Total Shareholder Return | 0.38% | 1.56% | 4.34% | 8.62% | 2.90% | 3.63% |